Helicobacter Pylori-induced Enlarged-fold Gastritis is Associated with Increased Mutagenicity of Gastric Juice, Increased Oxidative DNA Damage, and an Increased Risk of Gastric Carcinoma
Overview
Authors
Affiliations
Background And Aim: The severe inflammation, increased cell proliferation and marked acid inhibition observed in subjects with Helicobacter pylori-associated enlarged-fold gastritis suggest that enlarged-fold gastritis may be a risk factor for gastric carcinoma. The purpose of the present study was to determine whether a relationship exists between enlarged-fold gastritis and gastric carcinoma.
Methods: One hundred and thirty-five H. pylori-positive patients with early gastric carcinoma and 141 age- and sex-matched H. pylori-positive controls without gastric carcinoma were involved in the study. The widths of gastric body folds were measured by double-contrast radiographs. The mutagenicity of gastric juice was assayed using the Ames test and Salmonella typhimurium TA-98 or TA-100 with S9-mix. Levels of 8-hydroxydeoxyguanosine (8-OHdG) in gastric mucosa were examined using high-performance liquid chromatographic-electrochemical detection.
Results: An upward shift in the distribution of gastric fold widths in H. pylori-positive patients with early gastric carcinoma was found. Enlarged-fold gastritis (fold width >/=5 mm) was observed in 81% of the patients with gastric carcinoma, compared with 46% of H. pylori-positive controls. The odds ratio for gastric carcinoma increased with increasing fold width to a maximum of 35.5 in persons with fold width >/=7 mm. The prevalence of diffuse-type early gastric carcinoma in the body region increased with increasing fold width. The mutagenicity of gastric juice from the patients with enlarged-fold gastritis was significantly higher than that in H. pylori-negative controls and H. pylori-positive patients without enlarged folds. Mucosal 8-OHdG levels in the body region of patients with enlarged-fold gastritis were significantly higher than in H. pylori-negative controls and H. pylori-positive patients without enlarged-fold gastritis. Eradication of H. pylori significantly decreased the mutagenicity of gastric juice and 8-OHdG levels in the gastric mucosa from patients with enlarged-fold gastritis.
Conclusion: A significant association is suggested between enlarged-fold gastritis and gastric carcinoma.
Kirita K, Futagami S, Nakamura K, Agawa S, Ueki N, Higuchi K DEN Open. 2024; 5(1):e70029.
PMID: 39534404 PMC: 11555298. DOI: 10.1002/deo2.70029.
Advanced Diagnostic and Therapeutic Endoscopy for Early Gastric Cancer.
Fujishiro M Cancers (Basel). 2024; 16(5).
PMID: 38473395 PMC: 10930798. DOI: 10.3390/cancers16051039.
Nagashima A, Okimoto K, Nakagawa R, Akizue N, Matsumura T, Oura H Sci Rep. 2023; 13(1):19661.
PMID: 37952025 PMC: 10640628. DOI: 10.1038/s41598-023-47000-3.
Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report.
Syam A, Miftahussurur M, Makmun D, Abdullah M, Rani A, Siregar G Gut Pathog. 2023; 15(1):25.
PMID: 37217981 PMC: 10202071. DOI: 10.1186/s13099-023-00551-2.
Toyoshima O, Nishizawa T World J Gastroenterol. 2022; 28(43):6078-6089.
PMID: 36483157 PMC: 9724483. DOI: 10.3748/wjg.v28.i43.6078.